FDA Regulatory Status The FDAs position is unambiguous: BPC-157 is not an approved drug for any medical condition
In the second tier sit peptides like Thymosin Alpha-1, which have regulatory approval for specific indications, meaningful human trial data, and plausible longevity mechanisms even if their specific application to healthy aging remains to be formally tested
Excluding patients who already had ESRD, the results showed that LN patients not on GLP-1Ras were twice as likely to progress to ESRD or dialysis dependence within five years compared to those using GLP-1Ras (OR 2.35, 95% CI 1.39, 3.976)
Continuous GH receptor stimulation, as seen with exogenous recombinant human GH (rhGH), can downregulate receptors and impair GH signaling
Ready to transform your figure and feel confident in your skin
Hartweg J, Farmer AJ, Holman RR, and Neil HAW